^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Zuplenz (ondansetron oral dispersible film)

    i
    Other names: ondansetron ODFS, ondansetron ODF
    Associations

    News

    Trials
    Company:
    Italfarmaco, Norgine, SELLAS Life Sciences, Vestiq Pharma, tesa
    Drug class:
    Serotonin 3 receptor antagonist
    Related drugs:
    Associations

    News

    Trials
    16d
    T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers (clinicaltrials.gov)
    P1, N=36, Terminated, National Cancer Institute (NCI) | Completed --> Terminated; Site plans to become a site for a multicenter study of this therapy
    Trial termination • IO biomarker
    |
    cyclophosphamide • fludarabine IV • Proleukin (aldesleukin) • Zuplenz (ondansetron oral dispersible film)
    4ms
    Evaluation of the Safety, Tolerability, and Efficacy of Preoperative Ondansetron Orally Dissolving Film for Prophylactic Antiemesis in Patients Undergoing Pulmonary Surgery (ChiCTR2500105051)
    P4, N=306, Not yet recruiting, Peking University Cancer Hospital; Peking University Cancer Hospital
    New P4 trial
    |
    Zuplenz (ondansetron oral dispersible film)
    4ms
    Efficacy and safety of ondansetron oral dissolving membrane combined with Huoxiang Zhengqi oral liquid in the prevention of delayed nausea and vomiting caused by hyperemetic chemotherapy: a randomized controlled clinical trial (ChiCTR2500106531)
    P2, N=84, Not yet recruiting, Affiliated Hospital of Southwest Medical University; Affiliated Hospital of Southwest Medical University
    New P2 trial
    |
    dexamethasone • Zuplenz (ondansetron oral dispersible film)
    9ms
    Evaluation of the efficacy and safety of ondansetron oral film in the prevention of postoperative nausea and vomiting after primary total joint arthroplasty (ChiCTR2500097588)
    P=N/A, N=330, Not yet recruiting, West China Hospital of Sichuan University; West China Hospital of Sichuan University
    New trial
    |
    Zuplenz (ondansetron oral dispersible film)
    almost2years
    Granisetron Versus Ondansetron for Nausea and Vomiting in Pediatric Age Group (clinicaltrials.gov)
    P=N/A, N=160, Completed, Ain Shams University
    New trial
    |
    Zuplenz (ondansetron oral dispersible film) • granisetron oral
    over4years
    LYTPET: Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment (clinicaltrials.gov)
    P2, N=150, Active, not recruiting, British Columbia Cancer Agency | Trial completion date: Dec 2020 --> Dec 2021 | Trial primary completion date: Dec 2020 --> Dec 2021
    Clinical • Trial completion date • Trial primary completion date
    |
    CD20 (Membrane Spanning 4-Domains A1)
    |
    CD20 positive
    |
    carboplatin • Rituxan (rituximab) • doxorubicin hydrochloride • ifosfamide • etoposide IV • vincristine • Zuplenz (ondansetron oral dispersible film) • cyclophosphamide intravenous